The new WHO 2022 category of molecularly defined renal carcinomas: Accessible to practicing pathologists

Am J Clin Pathol. 2023 Dec 1;160(6):545-548. doi: 10.1093/ajcp/aqad101.

Authors

Steven Christopher Smith¹, Sara E Wobker²

Affiliations

¹ Departments of Pathology, Surgery, and Massey Comprehensive Cancer Center, VCU School of Medicine, and Richmond Veterans Affairs Medical Center, Richmond, VA, US.
² Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, US.

PMID: 37589571
DOI: 10.1093/ajcp/aqad101

No abstract available

Keywords: RCC classification; TFE3; TFEB; amplified RCC; rearranged RCC.

Publication types

Editorial

MeSH terms

Basic Helix-Loop-Helix Leucine Zipper Transcription Factors / genetics
Carcinoma, Renal Cell* / diagnosis
Carcinoma, Renal Cell* / genetics
Humans
Kidney Neoplasms* / diagnosis
Kidney Neoplasms* / genetics
Pathologists
Translocation, Genetic
World Health Organization

Substances

Basic Helix-Loop-Helix Leucine Zipper Transcription Factors